Digital Therapeutics Market Size, Growth, Demands Outlook and Forecasts to 2030

According to the research report, the global digitaltherapeutics market size is expected to touch USD 17.34 Billion by 2030, from USD 3.88 Billion in 2022, growing with a significant CAGR of 20.5% from 2022 to 2030.

Digital Therapeutics Market Size 2020 to 2030

The digital therapeutics market report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global digital therapeutics market in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global digital therapeutics market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global digital therapeutics market during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/1128

Scope of the Digital Therapeutics Market Report

Report Scope	Details
Market Size	USD 17.34 Billion by 2030
Growth Rate	CAGR of 20.5% From 2022 to 2030
Base Year	2021
Historic Data	2017 to 2021
Forecast Period	2022 to 2030
Segments Covered	Product, Application, Sales Channel
Regional Scope	North America, Europe, Asia Pacific, Rest of the World

This study covers a detailed segmentation of the global digital therapeutics market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global digital therapeutics market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

Fitbit Health Solutions
2MORROW, Inc.
Medtronic Plc.
Livongo Health, Inc.
Pear Therapeutics, Inc.
Omada Health, Inc.
Resmed, Inc. (Propeller Health)
Proteus Digital Health, Inc.
Welldoc, Inc.
Voluntis, Inc.
Canary Health Inc.
Noom, Inc.
Mango Health Inc.
Dthera Sciences

Market Segmentation

By Product

Device
Software

By Sales Channel

Business-to-Consumer (B2C)
- Caregiver
- Patient
Business-to-Business (B2B)
- Healthcare Provider
- Employer
- Others

By Application

Obesity
Diabetes
Central Nervous System (CNS) Disease
Gastrointestinal Disorder (GID)
Cardiovascular Disease (CVD)
Smoking Cessation
Respiratory Disease
Others

By Regional Outlook

North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
Asia Pacific
- China
- India
- Japan
- South Korea
Latin America
MEA

Research Methodology

The research methodology adopted by analysts for compiling the global digital therapeutics market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global digital therapeutics market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. DataSources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Digital Therapeutics Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Market SWOT Analysis

Chapter 5. COVID 19 Impact on Digital Therapeutics Market

5.1. Covid-19: Digital Therapeutics Industry Impact
5.2. Digital Therapeutics Business Impact Assessment: Covid-19
5.2.1. Distribution Channel Challenges/Disruption
5.2.2. Market Trends and Digital Therapeutics Opportunities in the COVID-19 Landscape
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Digital Therapeutics Manufacturers to deal with Covid-19 Pandemic Scenario

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing Penetration of Digital Healthcare Applications & Platforms
6.1.1.2. Rapid Adoption of Smartphones & Tablets
6.1.2. Market Restraints
6.1.2.1. Lack of Proper Monetization Strategy
6.1.3. Market Opportunities
6.1.3.1. Implementation of Machine Learning and Artificial Intelligence in Digital Therapeutics Platforms

Chapter 7. Global Digital Therapeutics Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Digital Therapeutics Market Revenue by Manufacturer (2016-2020)
7.1.1.2. Digital Therapeutics Market Revenue Market Share by Manufacturer (2016-2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Capacity Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers

Chapter 8. Global Digital Therapeutics Market, By Product Type

8.1. Digital Therapeutics Market, by Product Type, 2019-2030
8.1.1. Device
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Software
8.1.2.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Digital Therapeutics Market, By Sales Channel

9.1. Digital Therapeutics Market, by Sales Channel, 2019-2030
9.1.1. Business-to-Consumer (B2C)
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.1.2. Caregiver
9.1.1.3. Patient
9.1.2. Business-to-Business (B2B)
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.2.2. Healthcare Provider
9.1.2.3. Employer
9.1.2.4. Others

Chapter 10. Global Digital Therapeutics Market, By Application

10.1. Digital Therapeutics Market, by Application, 2019-2030
10.1.1. Obesity
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Diabetes
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Central Nervous System (CNS) Disease
10.1.3.1. Market Revenue and Forecast (2019-2030)
10.1.4. Gastrointestinal Disorder (GID)
10.1.4.1. Market Revenue and Forecast (2019-2030)
10.1.5. Cardiovascular Disease (CVD)
10.1.5.1. Market Revenue and Forecast (2019-2030)
10.1.6. Smoking Cessation
10.1.6.1. Market Revenue and Forecast (2019-2030)
10.1.7. Respiratory Disease
10.1.7.1. Market Revenue and Forecast (2019-2030)
10.1.8. Others
10.1.8.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Digital Therapeutics Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Product Type (2019-2030)
11.1.2. Market Revenue Forecast by Sales Channel (2019-2030)
11.1.3. Market Revenue Forecast by Application (2019-2030)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2019-2030)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2019-2030)
11.2. Europe
11.2.1. Market Revenue Forecast by Product Type (2019-2030)
11.2.2. Market Revenue Forecast by Sales Channel (2019-2030)
11.2.3. Market Revenue Forecast by Application (2019-2030)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2019-2030)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2019-2030)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2019-2030)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2019-2030)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product Type (2019-2030)
11.3.2. Market Revenue Forecast by Sales Channel (2019-2030)
11.3.3. Market Revenue Forecast by Application (2019-2030)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2019-2030)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2019-2030)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2019-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2019-2030)
11.4. LATAM
11.4.1. Market Revenue Forecast by Product Type (2019-2030)
11.4.2. Market Revenue Forecast by Sales Channel (2019-2030)
11.4.3. Market Revenue Forecast by Application (2019-2030)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2019-2030)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2019-2030)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product Type (2019-2030)
11.5.2. Market Revenue Forecast by Sales Channel (2019-2030)
11.5.3. Market Revenue Forecast by Application (2019-2030)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2019-2030)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2019-2030)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2019-2030)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2019-2030)

Chapter 12. Company Profiles

12.1. Fitbit Health Solutions
12.1.1. Company Overview, Business Information, Manufacturing Area
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue, Price and Gross Margin (2016-2020)
12.1.4. Recent Developments and Strategies
12.2. 2MORROW, Inc.
12.2.1. Company Overview, Business Information, Manufacturing Area
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue, Price and Gross Margin (2016-2020)
12.2.4. Recent Developments and Strategies
12.3. Medtronic Plc.
12.3.1. Company Overview, Business Information, Manufacturing Area
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue, Price and Gross Margin (2016-2020)
12.3.4. Recent Developments and Strategies
12.4. Livongo Health, Inc.
12.4.1. Company Overview, Business Information, Manufacturing Area
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue, Price and Gross Margin (2016-2020)
12.4.4. Recent Developments and Strategies
12.5. Pear Therapeutics, Inc.
12.5.1. Company Overview, Business Information, Manufacturing Area
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue, Price and Gross Margin (2016-2020)
12.5.4. Recent Developments and Strategies
12.6. Omada Health, Inc.
12.6.1. Company Overview, Business Information, Manufacturing Area
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue, Price and Gross Margin (2016-2020)
12.6.4. Recent Developments and Strategies
12.7. Resmed, Inc. (Propeller Health)
12.7.1. Company Overview, Business Information, Manufacturing Area
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue, Price and Gross Margin (2016-2020)
12.7.4. Recent Developments and Strategies
12.8. Proteus Digital Health, Inc.
12.8.1. Company Overview, Business Information, Manufacturing Area
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue, Price and Gross Margin (2016-2020)
12.8.4. Recent Developments and Strategies
12.9. Welldoc, Inc.
12.9.1. Company Overview, Business Information, Manufacturing Area
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue, Price and Gross Margin (2016-2020)
12.9.4. Recent Developments and Strategies
12.10. Voluntis, Inc.
12.10.1. Company Overview, Business Information, Manufacturing Area
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue, Price and Gross Margin (2016-2020)
12.10.4. Recent Developments and Strategies